Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cance... ( February 10 2011 (BRONX NY) The Am...)

Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research

Date:2/10/2011

February 10, 2011 (BRONX, NY) The American Association for Cancer Research (AACR), the world's largest organization dedicated to cancer research, has awarded Susan Band Horwitz, Ph.D., the Rose C. Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, its Eighth Award for Lifetime Achievement in Cancer Research.

Dr. Horwitz, who is also the associate director for experimental therapeutics at the Albert Einstein Cancer Center, is being honored for her pioneering research that established the mechanism of action of the cancer chemotherapeutic drug Taxol, also known as paclitaxel, which prompted the development of this drug as an important therapy for many common solid tumors. Taxol has been used by more than one million patients worldwide to treat cancers of the ovary, breast and lung.

"Dr. Horwitz has had a direct impact on millions of cancer patients around the world through her work in understanding the mechanisms of action of paclitaxel and other cytotoxic drugs," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "Her remarkable career and pivotal scientific contributions have influenced our understanding of how cancer drugs work and how to translate that knowledge into improved strategic treatments."

"This award has great meaning for me because it results from a decision made by my peers," said Dr. Horwitz. "This honor recognizes my laboratory and all of the students, fellows and visiting scientists, who have contributed so much to my research program."

Dr. Horwitz began investigating Taxol in 1977, after its isolation from the bark of the Pacific yew tree, Taxus brevifolia, by two medicinal chem
'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Susan Band Horwitz, Ph.D., receives AACR Award for Lifetime Achievement in Cancer Research
2. Susan G. Komen awards Case Western Reserve nearly $500,000 to study breast cancer in older women
3. Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™
4. Susan G. Komen for the Cure awards grant to Lombardis V. Craig Jordan
5. Susan Nedza MD, MBA, FACEP Named Vice President, Strategic Clinical Solutions of HealthyCircles
6. Emmy-Award Winning Actress Susan Lucci to Receive Philanthropic Leadership Award at 7th Annual Cure for Sure Dinner
7. Highest prize in public health -- the Frank A. Calderone Prize -- to Susan Baker, pioneer
8. MAYO Communications Retained by MAMMOJAM 2010 Dr. Susan Love Research Foundation Event
9. DC Dermatologist Dr. Susan T. Elliott Selected Best Doctor by Washingtonian Magazine
10. The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area
11. Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC)

Post Your Comments:

Related Image:

Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research

(Date:5/24/2013)... General Data Company Inc., a leading ... data management products and solutions, has announced that ... of Durham, North Carolina, a leading manufacturer and ... clinical and research pathology marketplace. TBS will become ... specialty products and solutions to hospitals, independent labs ...

(Date:5/24/2013)... first conference of its kind, Impacts World 2013 ... decision makers from politics, business and civil society ... climate impact research across sectors and scales. , ... 2013 on May 27th, 1pm to 1:55pm and ... Speakers include: , Connie Hedegaard, EU ...

(Date:5/24/2013)... can healthy people who hear voices help schizophrenics? Finding the ... at the University of Bergen. , Researchers from the Bergen ... on how to help schizophrenics, who hear voices. The way ... voices, but who do not suffer from a mental illness. ... processes causing people to hear voices. A recent report published ...

(Date:5/24/2013)... May 24, 2013 The Icahn School ... International (CDI) exclusive license rights to commercially develop ... medicine applications. These cells are capable of further differentiation ... cardiomyocytes, endothelial cells, and vascular smooth muscle cells, and ... damaged heart tissue. , The original agreement announced in ...

(Date:5/24/2013)... The creative flair and design talent of graduating students ... Textiles and Clothing (ITC) have won applause from the ... 22 May at The Mira Hong Kong. ... various knitwear producers and yarn suppliers, the annual Knitwear ... from 20 graduating students majoring in knitwear design. The ...

Breaking Medicine News(10 mins):Health News:General Data Acquires Triangle Biomedical Sciences 2 Health News:General Data Acquires Triangle Biomedical Sciences 3 Health News:Help at hand for schizophrenics 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3 Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4 Health News:PolyU Stages Knitwear Fashion Show 2

[0] General Data Acquires Triangle Biomedical Sciences [0] Impacts conference on climate change effects [0] Help at hand for schizophrenics [0] Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles [0] PolyU Stages Knitwear Fashion Show

... from Strong International Performance and InLight ... Equipment Sales, ... personal and environmental radiation,monitoring, today reported record performance in its first fiscal ... -- Revenue reached a record $21.8 million on higher international revenues ...

... Sensitive Customer Health Care ... Data on Laptops and Desktops, ... global,leader in enterprise data protection, today announced that Payformance,Health, a ... Funds Transfer (EFT) and Electronic Remittance,Advice (ERA) services, has standardized ...

... Enables Improved Patient Safety and Office ... ... Jan. 31 Kryptiq, the leading provider,of next generation healthcare ... A four-hospital,organization with 55 physician clinics in the Springfield, MO ...

... 31 Oncology focused,biopharmaceutical product development company ... finalized its Rhitol(TM) Phase II clinical trial,with ... treatment cycle. Rhitol(TM),is evaluated as treatment for ... (GvHD) intolerant or resistant to standard immunosuppressive,treatment., ...

... ... -- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical ... Imaging, -- Reaffirms Expected Non-GAAP EPS CAGR of at ... Through 2010, Subject to Certain Assumptions, -- Completes Sale of Medical Imaging Business, Reports as Discontinued, ...

... 31, 2008 The Procter &,Gamble Company (NYSE: ... to,$21.6 billion for the quarter. Sales were up behind ... and double-digit organic,growth in developing regions. Organic volume increased ... the quarter. Diluted earnings per,share increased 17 percent to ...

Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security CoxHealth Deploys Kryptiq ePrescribing Solution Kiadis Pharma Announces Successful Completion of Rhitol(TM) Phase II Clinical Study Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company

(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...

(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...

(Date:5/23/2013)... , May 23, 2013 Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...

Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3 BioElectronics and Pulsed Shortwave Therapy Make Progress 2 Cardinal Health Selects Datameer for Healthcare Data Discovery 2

[0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results [0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] Cardinal Health Selects Datameer for Healthcare Data Discovery

... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...

... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...

Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2 TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....

Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....

Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....

5 mm jaws with teeth provide secure fixation of occular structures....

Medicine Products:

Pierse Type Fine Skeleton Forceps Pierse Type Micro Skeleton Forceps Pierse Type Colibri Forceps Green Straight Fixation Forceps